Insulin Glargine: a review 8 years after its introduction

Inpatient insulin therapy

(2011) Susan Shapiro Braithwaite   Current Opinion in Endocrinology Diabetes and Obesity

Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs

(2008) G. Papa et al.   ACTA DIABETOLOGICA

Exenatide: Its position in the treatment of type 2 diabetes

(2008) B. Guerci et al.   ANNALES D ENDOCRINOLOGIE

Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials

(2008) Sten Madsbad et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes

(2008) J. C. Pickup et al.   DIABETES CARE

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

(2008) J. Rosenstock et al.   DIABETOLOGIA

Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVETM study

(2008) A. Dornhorst et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized, Controlled Trial Comparing Twice-a-Day Insulin Glargine Mixed With Rapid-Acting Insulin Analogs Versus Standard Neutral Protamine Hagedorn (NPH) Therapy in Newly Diagnosed Type 1 Diabetes

(2008) K. Hassan et al.   PEDIATRICS

Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?

(2007) R. E. Buckingham et al.   DIABETES OBESITY & METABOLISM